This study centers upon Junctional Adhesion Molecule-A (JAM-A), a transmembrane immunoglobulin superfamily protein with numerous physiological functions (reviewed by [7]), whose overexpression in invasive breast cancer patient tissues has been associated with aggressive or recurrent disease and increased risk of metastasis [8,9,10,11,12]. This evidence concerns the gene F11R and breast cancer.